> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA Clears Copan Diagnostics’ Colibrí
- URL: https://www.fdaweb.com/fda-clears-copan-diagnostics-colibri/
- Published: 2022-10-10T12:00:00.000Z
- Updated: 2026-09-14T18:02:24.000Z
- Author: David McFarland
- Tags: Devices, #legacy-id-D5152934

FDA has cleared a Copan Diagnostics 510(k) for its Colibrí, a semi-automated pre-analytical processor that is part of the company’s WASPLab laboratory automation system. The *in vitro* automated specimen workup platform is designed to prepare tests for antibiotic susceptibility testing. It comprises the Colibrí Vision System and Colibrí Preparation Station, according to the company. The device automatically picks isolated colonies for further workup and investigations, the company says, adding that the colonies are designated by the laboratory technologist or automatically by Copan’s advanced artificial intelligence, PhenoMatrix TAG.